Benign Prostatic Hypertrophy (BPH) Clinical Trial
Official title:
A Randomized, Open-label, Oral Single Dosing, Two-way Crossover Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 After a Single Oral Dose in Healthy Male Subjects
This study is a randomized, open-label, oral single dosing, two-way crossover clinical trial to evaluate the effects of food on the bioavailability of CKD-397 after a single oral dose in healthy male subjects
To healthy male subjects of sixteen(16), following treatments are administered dosing in each
period and wash-out period is a minimum of 10 days.
Treatment A: CKD-397 1T under Fasting condition Treatment B: CKD-397 1T under Fed condition
(high fat meals). Pharmacokinetic blood samples are collected up to 72hrs. Safety and
pharmacokinetic are assessed.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01330927 -
Dose Response Study of VA106483 in Males With Nocturia and Benign Prostatic Hypertrophy (BPH)
|
Phase 1 |